Connect with us

Health

Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds – Science Daily

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new…

Published

on

Article feature image

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Should you pack your COVID-19 vaccine card for your next trip? – WAFB
Article feature image
Long-Term Complications in Youth-Onset Type 2 Diabetes – nejm.org